Nureca Limited Reports 87% Growth for Q4 FY25, Expands Reach with Swiggy and Release Strategic Priorities for FY 26

Mumbai, Maharashtra, India Key Highlights: Strong Financial Performance Q4 FY25 (Jan–Mar 2025) Revenue surged 87% to ₹31.74 crore (from Rs. 16.97 crore in Q4 FY24) EBIDTA improved 156% to ₹3.2 crore (from Rs. -5.6 crore in Q4 FY24) … Read more

Nureca Limited’s Manufacturing Subsidiary Secures US FDA Registration

Nureca Technologies Private Limited, the manufacturing subsidiary of Nureca Limited, has successfully completed its annual registration with the United States Food and Drug Administration (US FDA). The company’s manufacturing facility in Mohali, Punjab is now officially listed under Registration Number: 3036779619. This registration authorizes Nureca Technologies to continue manufacturing and exporting a suite of … Read more